On Tuesday, Replimune Group Inc (NASDAQ: REPL) was -77.24% drop from the session before settling in for the closing price of $12.32. A 52-week range for REPL has been $6.44 – $17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -14.85% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 8.57%. With a float of $62.53 million, this company’s outstanding shares have now reached $77.09 million.
In an organization with 479 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Replimune Group Inc (REPL) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Replimune Group Inc stocks. The insider ownership of Replimune Group Inc is 18.88%, while institutional ownership is 93.95%. The most recent insider transaction that took place on May 20 ’25, was worth 260,169. In this transaction Director of this company sold 32,279 shares at a rate of $8.06, taking the stock ownership to the 1,405,071 shares. Before that another transaction happened on May 20 ’25, when Company’s Chief Medical Officer sold 7,952 for $8.06, making the entire transaction worth $64,093. This insider now owns 146,933 shares in total.
Replimune Group Inc (REPL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 8.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.14% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
You can see what Replimune Group Inc (REPL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -1.71 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Let’s dig in a bit further. During the last 5-days, its volume was 20.34 million. That was better than the volume of 1.77 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 49.79%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 1.14%, which indicates a significant decrease from 1.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.79 in the past 14 days, which was higher than the 0.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.44, while its 200-day Moving Average is $11.02. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $3.35. Second resistance stands at $3.89. The third major resistance level sits at $4.23. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.14. The third support level lies at $1.59 if the price breaches the second support level.
Replimune Group Inc (NASDAQ: REPL) Key Stats
There are 77,087K outstanding shares of the company, which has a market capitalization of 216.23 million. As of now, sales total 0 K while income totals -247,300 K. Its latest quarter income was 0 K while its last quarter net income were -74,130 K.
